Publications by authors named "Chris LaGanke"

Claim this Profile
C
Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY).
Stanley L Cohan, Harold Moses, Jonathan Calkwood, Carlo Tornatore, Chris LaGanke

Mult Scler Relat Disord· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Edward Fox, Keith Edwards, Gordon Burch, Daniel R Wynn, Chris LaGanke

Mult Scler Relat Disord· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy.
Molly R Perkins, Caroline Ryschkewitsch, Julia C Liebner, Maria Chiara G Monaco, Danielle Himelfarb, Chris LaGanke

PLoS Pathog· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis